221 related articles for article (PubMed ID: 8111805)
1. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
2. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
3. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Wakui K; Takemae T; Kobayashi S
No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC].
Kameyama S; Fujii Y; Koike T; Tanaka R; Takahashi H
No Shinkei Geka; 1992 Jul; 20(7):749-55. PubMed ID: 1630565
[TBL] [Abstract][Full Text] [Related]
8. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
Iwabuchi S; Takatori M; Okabe K
Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
10. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
11. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
14. Disseminated intravascular coagulation after hepatic resection.
Tsuzuki T; Toyama K; Nakayasu K; Iida S; Ueda M; Toizumi A
Surgery; 1990 Feb; 107(2):172-6. PubMed ID: 2154054
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of FDP-D-dimer in DIC and pre-DIC].
Takagi M; Wada H; Tanigawa M; Iwasaki E; Deguchi A; Mori Y; Suzuki H; Ohkubo I; Endou T; Deguchi K
Rinsho Byori; 1990 Jul; 38(7):806-12. PubMed ID: 2205744
[TBL] [Abstract][Full Text] [Related]
17. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
18. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
Nishiyama T; Matsukawa T; Hanaoka K
Crit Care Med; 2000 May; 28(5):1419-22. PubMed ID: 10834689
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
20. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]